H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 3.98 CNY -1.24%
Market Cap: 19.7B CNY
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Net Income Forecast
See Also
Price Target
Average
+39%
Revenue
Forecast
+8%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

Price Targets Summary
Hubei Biocause Pharmaceutical Co Ltd

There are no price targets for Hubei Biocause Pharmaceutical Co Ltd.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hubei Biocause Pharmaceutical Co Ltd Competitors:
Price Targets
B
BVH
BaoViet Holdings
3% Downside
UNM
Unum Group
18% Upside
GL
Globe Life Inc
12% Upside
NN
NN Group NV
2% Upside
B
BVH
BaoViet Holdings
3% Downside
UNM
Unum Group
18% Upside
GL
Globe Life Inc
12% Upside
NN
NN Group NV
2% Upside
NHF
NIB Holdings Ltd
5% Upside
MFSL
Max Financial Services Ltd
26% Upside
7157
Lifenet Insurance Co
20% Upside
PST
Poste Italiane SpA
3% Downside

Revenue
Forecast

Revenue Estimate
Hubei Biocause Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Hubei Biocause Pharmaceutical Co Ltd's revenue is 61%. The projected CAGR for the next 8 years is -43%.

61%
Past Growth
-43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Hubei Biocause Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hubei Biocause Pharmaceutical Co Ltd's stock price target?
Not Available

Hubei Biocause Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Hubei Biocause Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-43%

For the last 8 years the compound annual growth rate for Hubei Biocause Pharmaceutical Co Ltd's revenue is 61%. The projected CAGR for the next 8 years is -43%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 240,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.